Orzechowska and his colleagues found that overexpression of PSEN1 was beneficial to improving the disease-free survival of intraluminal breast cancer, while low expression of PSEN1 was instrumental in the disease-free survival of triple-negative breast cancer (24). Here, PSEN1 is linked to breast cancer.